AI unveils secrets of protein stability

Patients who had a hysterectomy at age 30 or younger had higher rates of regret compared with those who had the procedure after 30, a

MADRID — Two positive phase III trials involving amivantamab (Rybrevant)-based regimens introduced new first- and second-line options in EGFR-mutant non-small cell lung cancer (NSCLC), though

The Eu­ro­pean Med­i­cines Agency is tak­ing aim at preterm birth drugs, with the agency’s safe­ty com­mit­tee rec­om­mend­ing that med­i­cines con­tain­ing 17-hy­drox­yprog­es­terone caproate, al­so known as